Whitehawk Therapeutics (WHWK) Assets Average (2011 - 2026)

Whitehawk Therapeutics (WHWK) has 16 years of Assets Average data on file, last reported at $139.0 million in Q1 2026.

• On a quarterly basis, Assets Average fell 8.63% year-over-year to $139.0 million in Q1 2026; TTM through Mar 2026 was $139.0 million, a 8.63% decrease from a year earlier, with the FY2025 full-year figure at $110.6 million, up 9.08% from the prior year.
• Assets Average for Q1 2026 stood at $139.0 million, down from $158.9 million in the prior quarter.
• Over the last five years, Assets Average for WHWK reached as high as $207.4 million in Q2 2025 and fell as low as $78.0 million in Q4 2024.
• Historically, Assets Average has averaged $146.3 million across 5 years, with a median of $150.1 million in 2022.
• Across the five-year window, Assets Average jumped 400.5% in 2022 and tumbled 42.66% in 2024, its largest moves.
• Year by year, Assets Average stood at $189.2 million in 2022, then decreased by 28.09% to $136.0 million in 2023, then sank by 42.66% to $78.0 million in 2024, then surged by 103.73% to $158.9 million in 2025, then slipped by 12.52% to $139.0 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $139.0 million in Q1 2026, $158.9 million in Q4 2025, and $173.9 million in Q3 2025.